Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Net Cash Flow: 2020-2024

Historic Net Cash Flow for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to -$13.3 million.

  • Burning Rock Biotech's Net Cash Flow rose 111.71% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 million, marking a year-over-year increase of 72.37%. This contributed to the annual value of -$13.3 million for FY2024, which is 70.02% up from last year.
  • Burning Rock Biotech's Net Cash Flow amounted to -$13.3 million in FY2024, which was up 70.02% from -$44.2 million recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's Net Cash Flow registered a high of $303.9 million during FY2020, and its lowest value of -$79.8 million during FY2022.
  • Moreover, its 3-year median value for Net Cash Flow was -$44.2 million (2023), whereas its average is -$45.8 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first plummeted by 123.19% in 2021, then soared by 70.02% in 2024.
  • MRY analysis of 5 years shows Burning Rock Biotech's Net Cash Flow stood at $303.9 million in 2020, then plummeted by 123.19% to -$70.5 million in 2021, then decreased by 13.26% to -$79.8 million in 2022, then surged by 44.61% to -$44.2 million in 2023, then skyrocketed by 70.02% to -$13.3 million in 2024.
  • Its last three reported values are -$13.3 million in FY2024, -$44.2 million for FY2023, and -$79.8 million during FY2022.